RPG Life Sciences has a global map of satisfied customers and continues

to provide accessible quality healthcare to society

Our People, Our Pride


Our Brave warriors making a difference during COVID-19 Outbreak

RPG Life Sciences is leading global trusted pharma brand

RPG Life Sciences, a part of RPG Enterprises, is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics and Synthetic APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines.

Recent News

ET Now
Yugal Sikri, MD, RPG Life Sciences speaks to ET Now on Q3FY24 results and Future Outlook..click for more details
02 Feb, 2024


Yugal Sikri, MD, RPG Life Sciences speaks to ET Now on Q3FY24 results and Future Outlook

Yugal Sikri, MD, RPG Life Sciences speaks to ET Now on Q3FY24 results and Future Outlook

- as per ET Now

Click for more details

02 Feb, 2024

ET Now Swadesh
Yugal Sikri, MD, RPG Life Sciences, speaks to ET Now Swadesh on Q3FY24 results..click for more details
02 Feb, 2024


Yugal Sikri, MD, RPG Life Sciences, speaks to ET Now Swadesh on Q3FY24 results

Yugal Sikri, MD, RPG Life Sciences, speaks to ET Now Swadesh on Q3FY24 results

- as per ET Now Swadesh

Click for more details

02 Feb, 2024

CNBC-TV18
Yugal Sikri, MD, RPGLS speaks to CNBC-TV18 on Q2FY24 and outlook..click for more details
19 Oct, 2023


Yugal Sikri, MD, RPGLS speaks to CNBC-TV18 on Q2FY24 and outlook

Yugal Sikri, MD, RPGLS speaks to CNBC-TV18 on Q2FY24 and outlook

 

- as per CNBC-TV18

Click for more details

19 Oct, 2023

BQ Prime
Yugal Sikri, MD, RPG Life Sciences on BQ Prime | Q2FY24 earnings and outlook..click for more details
19 Oct, 2023


Yugal Sikri, MD, RPG Life Sciences on BQ Prime | Q2FY24 earnings and outlook

Yugal Sikri, MD, RPG Life Sciences on BQ Prime | Q2FY24 earnings and outlook

 

- as per BQ Prime

Click for more details

19 Oct, 2023

ET Now Swadesh
Yugal Sikri, MD, RPG Life Sciences speaks to ET Now Swadesh on Q2FY24 earnings and business outlook..click for more details
19 Oct, 2023


Yugal Sikri, MD, RPG Life Sciences speaks to ET Now Swadesh on Q2FY24 earnings and business outlook

Yugal Sikri, MD, RPG Life Sciences speaks to ET Now Swadesh on Q2FY24 earnings and business outlook

- as per ET Now Swadesh

Click for more details

19 Oct, 2023

ET Now
Yugal Sikri, MD, RPG Life Sciences, shares insights on organic and inorganic growth strategies...click for more details
19 Jun, 2023


Yugal Sikri, MD, RPG Life Sciences, shares insights on organic and inorganic growth strategies.

FY24 capex and price trends: Boosting margins with operating efficiencies. Focus on merger and acquisition activities. Yugal Sikri, MD, RPG Life Sciences, shares insights on organic and inorganic growth strategies.

- as per ET Now

Click for more details

19 Jun, 2023

CNBC-TV18
Yugal Sikri, MD, RPG Life Sciences spoke to CNBC-TV18 on Q4 earnings..click for more details
02 May, 2023


Yugal Sikri, MD, RPG Life Sciences spoke to CNBC-TV18 on Q4 earnings

Yugal Sikri, MD, RPG Life Sciences spoke to CNBC-TV18 on Q4 earnings

 

- as per CNBC-TV18

Click for more details

02 May, 2023

ET Now Swadesh
Yugal Sikri, Managing Director, RPG Life Sciences, commented on the company’s performance in Q4 FY23..click for more details
02 May, 2023


Yugal Sikri, Managing Director, RPG Life Sciences, commented on the company’s performance in Q4 FY23

Yugal Sikri, Managing Director, RPG Life Sciences, commented on the company’s performance in Q4 FY23 to ET Now Swadesh

 

- as per ET Now Swadesh

Click for more details

02 May, 2023



New Products

Employee Connect Initiatives

We believe in people as our best assets. So, we at RPGLS have several Employee Connect Initiatives such as Hello Happiness Forums, Happy Talk, etc.

Read More at Employee Connect

Managing DirectorRPG Life Sciences Limited

Operations

Business Portfolio

RPG Life Sciences operates through three business verticals – API, Domestic Formulations and International Formulations.

Therapeutic Focus

We have a diverse product portfolio spanning over 10 therapeutic areas including Nephrology, Oncology, Urology, Respiratory, etc.

Facilities

Our Formulations facilities are located at Ankleshwar, Gujarat and Synthetic API facility is located at Navi Mumbai.

Quality

Quality is considered paramount by us during development, manufacture and testing of our products.

Company Awards

Flexible rewards policy and work-life balance programs reflect our emphasis on employees.

Research and Development

Formulation Research & Development forms the most significant pillar of our growth strategy.

Corporate Social Responsibility

Our vision is to drive holistic empowerment of the community around the local vicinity of our plants and society at large.

Environment and Sustainability

Environment, Health and Safety has been one of our key areas where there has been a constant endeavor to excel.

Our History and Milestones

RPGLS @ Industry Platforms

Investor Relations

Investor Relations Section includes one click access to statutory information and data sought by the investors. Investors can have a look at Company Presentations, Financial Reports, Annual Reports, Corporate Governance reports, Composition of Committees, etc.

Annual Reports

And we have products that take care of patients make people happy

70,000+ doctors in 52 countries prescribe RPG Life Sciences products for over 10 therapies. Our leading brands are: